Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd., a foreign private issuer, on January 24, 2019. The filing serves to update publicly disclosed descriptions of the Company's business and risk factors. The disclosure updates are contained in Exhibit 99.1 and are incorporated by reference into the Company's Registration Statements on Form S-8 and Form F-3.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural update regarding business descriptions and risk factors rather than a financial results report.
Material Changes
The Company is updating certain aspects of its business and risk factor disclosures. No specific financial or operational changes are detailed in the cover letter of this filing.
Guidance, Outlook, and Risks
The filing explicitly states its purpose is to update risk factors. However, the specific content of these updated risks is located in Exhibit 99.1, which is not included in the provided text. No management commentary, guidance, or outlook is present in this document.
Key Facts for Investor Verification
- Verify the specific content of the updated business descriptions and risk factors in Exhibit 99.1.
- Confirm the incorporation of this filing into Registration Statements 333-214817, 333-220015, 333-225003, 333-219614, and 333-212432.
- Note that this filing contains no financial performance data for the period.